Piperidine propionamide as a scaffold for potent sigma-1 receptor antagonists and mu opioid receptor agonists for treating neuropathic pain

Eur J Med Chem. 2020 Apr 1:191:112144. doi: 10.1016/j.ejmech.2020.112144. Epub 2020 Feb 14.

Abstract

We designed and synthesized a novel series of piperidine propionamide derivatives as potent sigma-1 (σ1) receptor antagonists and mu (μ) opioid receptor agonists, and measured their affinity for σ1 and μ receptors in vitro through binding assays. The basic scaffold of the new compounds contained a 4-substituted piperidine ring and N-aryl propionamide. Compound 44, N-(2-(4-(4-fluorobenzyl) piperidin-1-yl) ethyl)-N-(4-methoxy-phenyl) propionamide, showed the highest affinity for σ1 receptor (Ki σ1 = 1.86 nM) and μ receptor (Ki μ = 2.1 nM). It exhibited potent analgesic activity in the formalin test (ED50 = 15.1 ± 1.67 mg/kg) and had equivalent analgesic effects to S1RA (σ1 antagonist) in a CCI model. Therefore, Compound 44, which has mixed σ1/μ receptor profiles, may be a potential candidate for treating neuropathic pain.

Keywords: Analgesic; Mu receptor agonists; Piperidine propionamide; Sigma-1 receptor antagonists.

MeSH terms

  • Amides / administration & dosage
  • Amides / chemistry
  • Amides / pharmacology*
  • Animals
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Formaldehyde
  • Guinea Pigs
  • Injections, Subcutaneous
  • Mice
  • Mice, Inbred ICR
  • Molecular Structure
  • Neuralgia / chemically induced
  • Neuralgia / drug therapy*
  • Neuralgia / pathology
  • Piperidines / administration & dosage
  • Piperidines / chemistry
  • Piperidines / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Opioid, mu / agonists*
  • Receptors, sigma / antagonists & inhibitors*
  • Sciatic Nerve / drug effects
  • Sciatic Nerve / pathology
  • Sigma-1 Receptor
  • Structure-Activity Relationship

Substances

  • Amides
  • Piperidines
  • Receptors, Opioid, mu
  • Receptors, sigma
  • Formaldehyde
  • piperidine
  • propionamide